Home
>
National Drug Code (NDC)
>
Ceftriaxone
Ceftriaxone - 25021-105-10 - (ceftriaxone)
Drug Information of Ceftriaxone
| Product NDC: | 25021-105 |
| Proprietary Name: | Ceftriaxone |
| Non Proprietary Name: | ceftriaxone |
| Active Ingredient(s): | 500 mg/1 & nbsp; ceftriaxone |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ceftriaxone
| Product NDC: | 25021-105 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065329 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091105 |
Package Information of Ceftriaxone
| Package NDC: | 25021-105-10 |
| Package Description: | 25 VIAL in 1 CARTON (25021-105-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Information of Ceftriaxone
| NDC Code | 25021-105-10 |
| Proprietary Name | Ceftriaxone |
| Package Description | 25 VIAL in 1 CARTON (25021-105-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 25021-105 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ceftriaxone |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20091105 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | CEFTRIAXONE SODIUM |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
